These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8618013)

  • 1. LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDa anchoring filament protein synthesized by epidermal cells.
    Marinkovich MP; Taylor TB; Keene DR; Burgeson RE; Zone JJ
    J Invest Dermatol; 1996 Apr; 106(4):734-8. PubMed ID: 8618013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 97-kDa linear IgA bullous dermatosis (LAD) antigen localizes to the lamina lucida of the epidermal basement membrane.
    Ishiko A; Shimizu H; Masunaga T; Hashimoto T; Dmochowski M; Wojnarowska F; Bhogal BS; Black MM; Nishikawa T
    J Invest Dermatol; 1996 Apr; 106(4):739-43. PubMed ID: 8618014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linear IgA bullous dermatosis with IgA antibodies exclusively directed against the 180- or 230-kDa epidermal antigens.
    Ghohestani RF; Nicolas JF; Kanitakis J; Claudy A
    J Invest Dermatol; 1997 Jun; 108(6):854-8. PubMed ID: 9182810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 97 kDa linear IgA bullous dermatosis antigen localizes in the lamina lucida between the NC16A and carboxyl terminal domains of the 180 kDa bullous pemphigoid antigen.
    Ishiko A; Shimizu H; Masunaga T; Yancey KB; Giudice GJ; Zone JJ; Nishikawa T
    J Invest Dermatol; 1998 Jul; 111(1):93-6. PubMed ID: 9665393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linear IgA bullous dermatosis. Characterization of a subset of patients with concurrent IgA and IgG anti-basement membrane autoantibodies.
    Chan LS; Traczyk T; Taylor TB; Eramo LR; Woodley DT; Zone JJ
    Arch Dermatol; 1995 Dec; 131(12):1432-7. PubMed ID: 7492134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel 105-kDa lamina lucida autoantigen: association with bullous pemphigoid.
    Cotell SL; Lapiere JC; Chen JD; Iwasaki T; Krusinski PA; Chan LS; Woodley DT
    J Invest Dermatol; 1994 Jul; 103(1):78-83. PubMed ID: 8027584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the expression of known basement membrane components with the linear IgA disease antigens using the novel substrate cylindroma.
    Wojnarowska F; Allen J; Collier PM; Leigh IM
    Br J Dermatol; 1999 Jul; 141(1):62-70. PubMed ID: 10417517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone.
    Zillikens D; Kawahara Y; Ishiko A; Shimizu H; Mayer J; Rank CV; Liu Z; Giudice GJ; Tran HH; Marinkovich MP; Brocker EB; Hashimoto T
    J Invest Dermatol; 1996 Jun; 106(6):1333-8. PubMed ID: 8752680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The localization of target antigens and autoantibodies in linear IgA disease is variable: correlation of immunogold electron microscopy and immunoblotting.
    Zhou S; Ferguson DJ; Allen J; Wojnarowska F
    Br J Dermatol; 1998 Oct; 139(4):591-7. PubMed ID: 9892901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
    Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
    Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Linear IgA bullous dermatosis in children with autoantibodies against 180 kDa pemphigoid antigen].
    Bérard F; Kanitakis J; Di Maio M; Ghohestani R; Hermier C; David L; Claudy A; Faure M
    Arch Pediatr; 1996 Apr; 3(4):345-7. PubMed ID: 8762956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone.
    Zillikens D; Kawahara Y; Ishiko A; Shimizu H; Mayer J; Rank CV; Liu Z; Giudice GJ; Tran HH; Marinkovich MP; Bröcker EB; Hashimoto T
    J Invest Dermatol; 1996 Mar; 106(3):465-70. PubMed ID: 8648178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subepidermal blistering disease with autoantibodies against a novel dermal 200-kDa antigen.
    Kawahara Y; Zillikens D; Yancey KB; Marinkovich MP; Nie Z; Hashimoto T; Nishikawa T
    J Dermatol Sci; 2000 Jun; 23(2):93-102. PubMed ID: 10808126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and partial characterization of a novel 105-kDalton lower lamina lucida autoantigen associated with a novel immune-mediated subepidermal blistering disease.
    Chan LS; Fine JD; Briggaman RA; Woodley DT; Hammerberg C; Drugge RJ; Cooper KD
    J Invest Dermatol; 1993 Sep; 101(3):262-7. PubMed ID: 8370962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel basement membrane antigen (p84) defined by sera with antibodies to both the epidermal and dermal side of split skin.
    Gao SQ; Bystryn JC
    J Invest Dermatol; 1994 Feb; 102(2):236-40. PubMed ID: 8106753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linear IgA disease with IgA antibodies directed against 200- and 280-kDa epidermal antigens.
    Fujimoto W; Ohtsu T; Toi Y; Nakanishi G; Arata J
    Br J Dermatol; 2000 Jun; 142(6):1213-8. PubMed ID: 10848750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the target antigen in chronic bullous disease of childhood and linear IgA disease of adults.
    Wojnarowska F; Whitehead P; Leigh IM; Bhogal BS; Black MM
    Br J Dermatol; 1991 Feb; 124(2):157-62. PubMed ID: 2003998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular overlap of the IgA target antigens in the subepidermal blistering diseases.
    Collier P; Wojnarowska F; Allen J; Kirtschig G
    Dermatology; 1994; 189 Suppl 1():105-7. PubMed ID: 8049544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal conditions of 1 M NaCl splitting technique to demonstrate basement membrane zone antigens in bullous pemphigoid, epidermolysis bullosa acquisita and linear IgA bullous dermatoses.
    Jenkins RE; Rodenas J; Bhogal BS; Black MM
    Dermatology; 1994; 189 Suppl 1():133-4. PubMed ID: 8049556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A subepidermal blistering dermatosis associated with coexistent IgG and IgA anti-dermal basement membrane zone antibodies; demonstration of IgG antibodies reactive against a 200-kDa dermal antigen.
    Watanabe M; Tsunoda T; Tagami H
    Eur J Dermatol; 2002; 12(6):603-6. PubMed ID: 12459541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.